1. Home
  2. LTRX vs NKTX Comparison

LTRX vs NKTX Comparison

Compare LTRX & NKTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LTRX
  • NKTX
  • Stock Information
  • Founded
  • LTRX 1989
  • NKTX 2015
  • Country
  • LTRX United States
  • NKTX United States
  • Employees
  • LTRX N/A
  • NKTX N/A
  • Industry
  • LTRX Computer Communications Equipment
  • NKTX Biotechnology: Pharmaceutical Preparations
  • Sector
  • LTRX Telecommunications
  • NKTX Health Care
  • Exchange
  • LTRX Nasdaq
  • NKTX Nasdaq
  • Market Cap
  • LTRX 106.5M
  • NKTX 123.5M
  • IPO Year
  • LTRX 2000
  • NKTX 2020
  • Fundamental
  • Price
  • LTRX $2.15
  • NKTX $1.73
  • Analyst Decision
  • LTRX Strong Buy
  • NKTX Strong Buy
  • Analyst Count
  • LTRX 5
  • NKTX 6
  • Target Price
  • LTRX $5.10
  • NKTX $14.80
  • AVG Volume (30 Days)
  • LTRX 252.4K
  • NKTX 418.5K
  • Earning Date
  • LTRX 05-08-2025
  • NKTX 05-14-2025
  • Dividend Yield
  • LTRX N/A
  • NKTX N/A
  • EPS Growth
  • LTRX N/A
  • NKTX N/A
  • EPS
  • LTRX N/A
  • NKTX N/A
  • Revenue
  • LTRX $143,159,000.00
  • NKTX N/A
  • Revenue This Year
  • LTRX N/A
  • NKTX N/A
  • Revenue Next Year
  • LTRX $3.20
  • NKTX N/A
  • P/E Ratio
  • LTRX N/A
  • NKTX N/A
  • Revenue Growth
  • LTRX N/A
  • NKTX N/A
  • 52 Week Low
  • LTRX $1.91
  • NKTX $1.31
  • 52 Week High
  • LTRX $4.55
  • NKTX $8.23
  • Technical
  • Relative Strength Index (RSI)
  • LTRX 44.90
  • NKTX 44.59
  • Support Level
  • LTRX $2.13
  • NKTX $1.70
  • Resistance Level
  • LTRX $2.31
  • NKTX $1.82
  • Average True Range (ATR)
  • LTRX 0.11
  • NKTX 0.10
  • MACD
  • LTRX -0.00
  • NKTX -0.01
  • Stochastic Oscillator
  • LTRX 35.94
  • NKTX 18.72

About LTRX Lantronix Inc.

Lantronix Inc is a networking company. It provides secure data access and management solutions for the Internet of Things (IoT) and information technology assets. It organizes its products and solutions into three product lines: Embedded IoT Solutions, IoT Systems Solutions, and Software and Services. The IoT System Solutions segment is the key revenue driver for the company. The company serves a diverse range of markets including healthcare, industrial, security, energy, transportation, and government networking. Its primary geographic markets are the Americas, Europe, the Middle East and Africa, and Asia Pacific Japan. The Americas contribute the vast majority of total revenue.

About NKTX Nkarta Inc.

Nkarta Inc is a clinical-stage biopharmaceutical company pioneering the development of allogeneic, off-the-shelf engineered natural killer (NK) cell therapies. The Company is engaged in leveraging the natural potent power of NK cells to identify and kill abnormal cells and recruit adaptive immune effectors to generate responses that are specific and durable. The company is combining its NK expansion platform technology with proprietary cell engineering technologies to generate an abundant supply of NK cells, engineer enhanced NK cell recognition of therapeutic targets, and improve persistence for sustained activity in the body for the treatment of cancer.

Share on Social Networks: